Shailesh Khatri
Affiliations: | University of Tennessee Health Science Center, Memphis, TN, United States |
Google:
"Shailesh Khatri"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Alwassil OI, Khatri S, Schulte MK, et al. (2021) NH- and N-Substituted Phenylguanidines as α7 Nicotinic Acetylcholine (nACh) Receptor Antagonists: Structure-Activity Relationship Studies. Acs Chemical Neuroscience |
Sadanandan SM, Kreko-Pierce T, Khatri SN, et al. (2020) Cannabinoid type 2 receptors inhibit GABAA receptor-mediated currents in cerebellar Purkinje cells of juvenile mice. Plos One. 15: e0233020 |
Khatri SN, Wu WC, Yang Y, et al. (2019) Mechanisms of GABA receptor enhancement of extrasynaptic GABA receptor currents in cerebellar granule cells. Scientific Reports. 9: 16683 |
Khatri SN, Wu WC, Yang Y, et al. (2019) Direction of action of presynaptic GABA receptors is highly dependent on the level of receptor activation. Journal of Neurophysiology |
Abdelkhalek AS, Alley GS, Alwassil OI, et al. (2018) "Methylene Bridge" to 5-HT3 Receptor Antagonists: Conformationally-Constrained Phenylguanidines". Acs Chemical Neuroscience |
Hueffer K, Khatri S, Rideout S, et al. (2017) Rabies virus modifies host behaviour through a snake-toxin like region of its glycoprotein that inhibits neurotransmitter receptors in the CNS. Scientific Reports. 7: 12818 |
Mitra S, Mucha M, Khatri SN, et al. (2016) Attenuation of Compulsive-Like Behavior Through Positive Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors in Non-Induced Compulsive-Like Mice. Frontiers in Behavioral Neuroscience. 10: 244 |
Alix K, Khatri S, Mosier PD, et al. (2016) Super-agonist, full agonist, partial agonist and antagonist actions of arylguanidines at h5-HT3A receptors. Acs Chemical Neuroscience |
Dukat M, Alix K, Worsham J, et al. (2013) 2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character. Bioorganic & Medicinal Chemistry Letters. 23: 5945-8 |